Literature DB >> 15183039

Deep vein thrombosis after elective cesarean section.

Anne Flem Jacobsen1, Anders Drolsum, Nils Einar Klow, Gunn Fallås Dahl, Erik Qvigstad, Per Morten Sandset.   

Abstract

INTRODUCTION: Pregnancy is associated with an overall 5-10 fold increased risk of venous thromboembolism (VTE). The absolute risk is highest during and shortly after delivery. Although operative delivery further increases the risk of VTE, there is no consensus on thromboprophylaxis after an elective cesarean. The aim of the present study was to investigate the frequency of symptomatic and asymptomatic deep venous thrombosis (DVT) in a low risk cesarean section population.
MATERIALS AND METHODS: Fifty-nine women undergoing elective cesarean section were screened for DVT using triplex Doppler sonography 3-5 days after delivery. Markers of activated coagulation were also followed and all women were screened for thrombophilia. Postoperative thromboprophylaxis was not given. During the same period all cases of symptomatic VTE were also recorded.
RESULTS: No DVT was detected by ultrasonography and no women developed symptomatic VTE during the six weeks follow-up period after delivery. Six women had thrombophilia. During the study period, a cesarean section was performed in 1067/5364 (20%) deliveries. Five of these women (0.47%) developed symptomatic pulmonary embolism, and all of these women had additional risk factors for VTE.
CONCLUSION: The risk of DVT among healthy pregnant women undergoing elective cesarean section is low, and general medical thromboprophylaxis is probably not justified.

Entities:  

Mesh:

Year:  2004        PMID: 15183039     DOI: 10.1016/j.thromres.2004.03.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  A review of Caesarean section techniques and postoperative thromboprophylaxis at a tertiary hospital.

Authors:  Chang Qi Hester Lau; Tuck Chin Tiffany Wong; Eng Loy Tan; Devendra Kanagalingam
Journal:  Singapore Med J       Date:  2016-04-08       Impact factor: 1.858

3.  Catheter-Directed Thrombolysis Is a Safe and Alternative Therapeutic Approach in the Management of Postpartum Lower Limb Deep Venous Thrombosis.

Authors:  B C Srinivas; Soumya Patra; C M Nagesh; Babu Reddy; C N Manjunath
Journal:  Int J Angiol       Date:  2014-05-12

4.  Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.

Authors:  Shannon M Bates; Saskia Middeldorp; Marc Rodger; Andra H James; Ian Greer
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

5.  Global incidence and case fatality rate of pulmonary embolism following major surgery: a protocol for a systematic review and meta-analysis of cohort studies.

Authors:  Mazou N Temgoua; Joel Noutakdie Tochie; Jean Jacques Noubiap; Valirie Ndip Agbor; Celestin Danwang; Francky Teddy A Endomba; Njinkeng J Nkemngu
Journal:  Syst Rev       Date:  2017-12-04

6.  Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens.

Authors:  A Kotaska
Journal:  BJOG       Date:  2018-03-07       Impact factor: 6.531

7.  Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women.

Authors:  Asha A Gader; Abed Elrahium D Haggaz; Ishag Adam
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

8.  Catheter-directed thrombolysis in management of postpartum lower limb deep venous thrombosis - A case series.

Authors:  B C Srinivas; Soumya Patra; C M Nagesh; Babu Reddy; C N Manjunath
Journal:  Indian Heart J       Date:  2016-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.